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Abstract 
Background. Indocyanine green retention rate at 15 minutes (ICGR15) is a useful marker 
of liver function in deciding on the extent of hepatectomy. To determine ICGR15 
regardless of liver condition, we sought to establish a formula for converted ICGR15 
based on conventional blood tests and technetium-99m galactosyl human serum albumin 
(99mTc-GSA) scintigraphy.  
Materials and methods. We measured liver function parameters, including ICGR15, in 
307 patients, including 265 liver cancer patients without biliary obstruction (no 
obstruction group) and 42 with biliary obstruction (obstruction group).  
Results. In the no obstruction group, multiple regression analysis identified blood pool 
clearance ratio (HH15), liver uptake ratio (LHL15) calculated by heart and liver activity 
between 3 and 15 minutes after injection of 99mTc-GSA, and serum hyaluronic acid as 
significant correlates (P<0.05). The calculated Converted ICGR15 was then equal to 
0.02*HA+0.276*(HH15*100)-0.501*(LHL15*100)+41.41. The mean difference 
between actual and converted ICGR15 was significantly lower in the obstruction than in 
the no obstruction group (P=0.031). A significantly larger proportion of patients of the 
obstruction group had lower converted ICGR15 than those of the no obstruction group 
(P=0.045).  
Conclusion. The converted ICGR15 is useful for evaluating hepatic function in patients 
with biliary obstruction who plan to undergo major hepatectomy. 
 
Key Words: liver resection; indocyanine green retention rate at 15 minutes (ICGR15); 
technetium-99m galactosyl human serum albumin liver scintigraphy; serum hyaluronic 
acid; converted formula 
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INTRODUCTION 
 
   The incidence of postoperative hepatic failure has markedly decreased in recent years 
following the introduction of adequate preoperative evaluation of hepatic function and 
estimation of resected liver volume as well as improvement in perioperative management 
[1]. In addition, evaluation of hepatic functional reserve has been developed and 
Child-Pugh classification is still widely applied worldwide [2-4]. However, it is 
sometimes difficult to plan the extent of hepatectomy by such a comprehensive scoring 
system consisting of the blood biochemical parameters for liver function without load for 
drug administration to the liver. Therefore, Seyama and Kokudo [5] proposed systematic 
criteria for hepatectomy based on the indocyanine green retention rate at 15 minutes 
(ICGR15) [5], and Takasaki et al. [6] also proposed the formula of permitted liver volume 
for resection based on the ICGR15 values. We have applied the latter formula to plan the 
extent of hepatic resection, and the estimated liver volume for resection by computed 
tomography (CT) was compared to the permitted volume [7, 8]. Many investigators have 
also used the ICGR15 as the most reliable test for hepatic functional reserve before 
hepatectomy [3, 9, 10], but in cases of obstructive biliary diseases or vascular shunt of 
hepatic circulation, the results of ICG might be worse than the true functional reserve [11, 
12]. Furthermore, some patients are allergic to indocyanine.  
   Recently, a new test that reliably assesses hepatic functional reserve, technetium-99m 
galactosyl human serum albumin (99mTc-GSA) scintigraphy, has been used in patients 
with liver diseases [13, 14]. This test is based on the fact that asialoglycoprotein receptors 
on hepatocytes reflect functional liver cells [15] and are not influenced by vascular shunt 
or obstructive jaundice [16, 17]. We confirmed previously that the results of 99mTc-GSA 
scintigraphy reflected impairment of background liver [11]. However, the range of the 
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liver uptake ratio (LHL15) was narrow, and therefore, it was sometimes difficult to decide 
on the extent of hepatectomy [11]. Therefore, 99mTc-GSA liver scintigraphy remains 
experimental in nature and has not yet replaced the ICGR15 test. To overcome the 
limitation of the ICG test described above, we sought to establish a modified formula for 
ICGR15 based on correlated parameters of conventional blood tests and 99mTc-GSA liver 
scintigraphy. We hypothesize that such a conversion formula can provide the true results 
of ICGR15 in patients with vascular shunt and obstructive jaundice. 
   In the present study, we examined the correlation between hepatic functional reserve 
and ICGR15 in 265 patients with liver diseases who did not have biliary or vascular 
obstruction or a porto-systemic shunt. Based on this analysis, a regression equation for 
the converted ICGR15 was constructed. In addition, we examined the validity of the 
conversion formula in 42 patients who had biliary obstruction. Our overall aim was to 
establish a conversion formula for ICGR15 based on conventional hepatic functional 
parameters suitable for all patients, irrespective of background liver disease. 
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MATERIALS AND METHODS 
Patients 
   The subjects included 307 patients who underwent hepatectomy in the Division of 
Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University 
Hospital (NUH) between January 1997 and June 2010. They included 222 males and 85 
females with a mean age of 65.210.6 years (SD, range 28-87 years). The liver diseases 
included hepatocellular carcinoma (n=164), intrahepatic cholangiocarcinoma (n=35), 
metastatic liver carcinoma (n=63), bile duct carcinoma (n=24), gallbladder carcinoma 
(n=14) and others (n=7). The background liver diseases included normal liver function 
(n=108), fatty liver (n=10), chronic viral liver diseases (n=161; including 75 with liver 
cirrhosis) and obstructive jaundice (n=28). Clinical data were retrieved from both 
anesthetic and medical records, as well as the NUH database, for the duration of the initial 
hospitalization and post-hepatectomy period. The existing liver diseases were diagnosed 
by clinical examination of multi-detector computed tomography (CT) and magnetic 
resonance (MR) imaging. Biliary tract status was examined by MR cholangiography or 
direct cholangiography. The study design was approved by the Ethics Review Board of 
NUGSBS, and a signed consent was obtained from each subject. 
 
Laboratory Tests 
ICGR15 is routinely used in our hospital to determine the volume of the liver to be 
resected based on Takasaki’s formula [6]. The estimated resected liver volume, excluding 
tumor volume (cm3), is measured by CT volumetry [2]. The planned hepatectomy is 
performed when the permitted resected volume of the liver is greater than the estimated 
resected volume of the liver. The permitted resected volume was calculated as [6]: 
  = 100 x (LOG(40)-LOG(ICGR15))/(2-LOG(ICGR15)) in cases of cirrhotic liver; 
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  = 100 x (LOG(50)-LOG(ICGR15))/(2-LOG(ICGR15)) in cases of non-cirrhotic liver. 
 
   Serum albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
platelet count, choline esterase, total cholesterol and prothrombin activity were measured 
using standard procedures. To measure ICGR15, indocyanine green (ICG) was injected 
intravenously at a dose of 0.5 mg/kg body weight with the 15-minute retention rate 
measured by a photopiece applied to the fingertip (RK-1000, Sumitomo Electric, Tokyo, 
Japan) without blood sampling [7, 8, 11]. Peripheral blood samples were also collected 
before meals for analysis of hyaluronic acid (HA), a marker of hepatic fibrosis and 
endothelial cell function in hepatic sinusoids [18]. Blood samples were centrifuged at 
3000 rpm for 15 min, and serum was stored at -80C. HA was assayed using a sandwich 
binding protein assay (SRL, Inc, Tokyo; normal range <50 ng/ml).  
 
Examination of 99mTc-GSA scintigraphy 
    For 99mTc-GSA scintigraphy, a bolus dose of 3 mg (185 MBq) of 99mTc-GSA (Nihon 
Medi-Physics, Nishinomiya, Japan) was injected into the antecubital vein. The hepatic 
uptake ratio of 99mTc-GSA (LHL15) and the blood pool clearance index (HH15) were 
then calculated after injection [19]. There was no limitation regarding the 99mTc-GSA test 
in patients with obstructive jaundice or hepatic vascular shunt. HH15 was then calculated 
as the uptake ratio of the heart at 15 min to that at 3 min, and LHL15 was calculated as the 
uptake ratio of the liver at 15 min to the liver plus the heart at 15 min (Figure 1a-b). 
Formulas for HH15 and LHL15 were as follows: 
HH15 = H15/H3 
LHL15 = L15/(L15+H15) 
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Statistical Analysis 
All continuous data were expressed as mean  SD. Data for different groups were 
compared using one-way analysis of variance (ANOVA) and examined by Student’s t-test. 
Correlations between two parameters were examined by calculating Pearson’s correlation 
coefficient. A two-tailed P value <0.05 was considered significant. The linear regression 
formula was calculated using the correlated parameters. PASW Statistics 18.0.0 for 
Windows (SPSS Inc., Chicago, IL) was used for all statistical analyses. 
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RESULTS 
Patient Demographics and Background Liver Disease 
   Of the 307 patients, 265 (195 males and 70 females, age 64.910.9 years) had no major 
vascular involvement or biliary obstruction. According to the Child-Pugh classification, 
248 patients were classified as A (94%) and 17 as B (6%). Partial resection was 
performed in 98 patients (37%), segmental or sectional resection in 69 (26%) and 
hemihepatectomy or extended hemihepatectomy in 98 (37%).  
     Patients with biliary obstruction (n=42) included 25 males and 17 females (age 
67.08.2 years). In these patients, liver diseases included intrahepatic 
cholangiocarcinoma (n=10), bile duct carcinoma (n=24), gallbladder carcinoma (n=5) 
and others (n=3). The background liver diseases included normal liver function (n=14) 
and obstructive jaundice (n=28). According to the Child-Pugh classification, 35 patients 
in this group were classified as A (83%) and 7 as B (17%). Partial resection was 
performed in 1 patient (2%), sectional resection in 2 (5%), and hemihepatectomy or 
extended hemihepatectomy in 39 (93%). 
 
Correlation between liver functional parameters and ICGR15 
   The mean ICGR15 in the 265 patients without biliary obstruction was 14.8±11.4%, and 
the mean in the 42 patients with biliary obstruction was 14.7±11.0%. There was thus no 
significant difference in actual volume between the groups (P=0.82). The mean total 
bilirubin levels at examination were 0.91±0.49 and 2.1±3.0 mg/dl in each group, 
respectively. Table 1 shows the correlation between each selected functional parameter of 
the liver (except total bilirubin level) and ICGR15 in 265 patients without biliary 
obstruction. The selected hepatic parameters were correlated against the ICGR15 using 
multiple linear regression analysis with the stepwise method (Table 2). In the first step, 
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HH15, LHL15, and serum HA levels correlated significantly with ICGR15. After 6 steps, 
these three variables were still significant (see model 2, Table 2). Based on this result, the 
regression equation was established as: 
Y (converted ICGR15) = 0.02  hyaluronic acid level (ng/ml) + 0.276  (HH15  100) - 
0.501  (LHL15  100) + 41.41 
 
Differences between estimated and actual ICGR15 
Using the above equation, a converted ICGR15 was calculated for all patients. Table 3 
shows the comparison of clinical data between patients with and without obstructive 
jaundice. Patients with jaundice had bile duct carcinomas more frequently in comparison 
with those without jaundice (p<0.05). Prevalence of Child-Pugh B patients in the 
jaundiced group were significantly more than that in the non-jaundiced group (p<0.05). 
In addition, the mean converted ICGR15 in patients without biliary obstruction tended to 
be higher than in patients with biliary obstruction but not significantly so (p=0.092). 
Furthermore, the variation of differences of ICGR15 in patients between the 
non-obstructed and obstructed jaundice groups was tended to be different but not 
statistically significant (p=0.066).  
In comparison with the actual ICGR15, the converted ICGR15 was reduced in 
106 of 265 patients (40%) without biliary obstruction and in 24 of 42 patients (57%) with 
biliary obstruction, which was significant between the two groups (p<0.05). Eighteen of 
the 106 patients (17%) without biliary obstruction and 10 of the 24 (42%) patients with 
biliary obstruction showed a significant reduction in the converted ICGR15 (over 10%) 
compared to the estimated value. Moreover, in comparison with patients without jaundice, 
blood loss and presence of major hepatectomy were more frequent in patients with 
jaundice (p<0.05), as was the associated hepatic failure (p<0.05).
Nanashima A et al., Page 10  
DISCUSSION 
 
  Tests using 99mTc-GSA scintigraphy, such as the hepatic uptake ratio (LHL15) [19, 20] 
and the blood pool clearance index (calculated as the ratio of heart activity at 15 minutes 
to heart activity at 3 minutes (HH15) [19, 20]), are very reliable and noninvasive methods 
for evaluating hepatic functional reserve without requiring blood sampling. 
Asialoglycoprotein is exclusively internalized into hepatocytes by a receptor [21]; thus, a 
decrease in the number of asialoglycoprotein receptors is specifically observed in injured 
livers [16]. Since 1996, our department has therefore used 99mTc-GSA scintigraphy 
preoperatively combined with ICGR15 and conventional liver function tests.  
On the other hand, hepatic fibrosis is also an important determinant of liver damage 
and hepatic dysfunction in chronic liver disease and after liver resection [22]. Damage to 
the hepatic endothelial cells results in a high serum HA level [18, 23], which is thought to 
be a marker of hepatic fibrosis. If endothelial cell function in the injured liver deteriorates 
[23], the serum HA level could be a useful marker of nonparenchymal liver cell function. 
The findings of our study and those of others showed that serum HA concentrations 
correlated inversely with measurements of functional liver reserve and the degree of 
hepatic fibrosis, suggesting that measuring the HA level might be useful for monitoring 
liver damage or predicting postoperative complications after hepatic resection [18, 23]. 
We have referred to this parameter preoperatively to predict postoperative complications 
since 2004.    
Here, we hypothesized that a converted ICGR15 could be calculated based on other 
hepatic functional parameters that are not affected by biliary obstruction. Kawamura et al. 
[9] measured converted ICGR15 using 99m-Tc GSA liver scintigraphy, with similar aims to 
the present study. As described above, the results of 99m-Tc GSA liver scintigraphy did not 
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seem to be affected by biliary obstruction [11, 12], and therefore, a more reliable 
estimation of liver functional reserve would be achieved. However, we decided that 
estimating the converted ICGR15 using only this parameter was problematic based on the 
availability of several other reliable liver function parameters. Therefore, we examined 
the correlations among various liver functions and ICGR15 in the present study. 
All the selected parameters correlated significantly with ICGR15, and subsequently, 
three parameters were selected as candidates for the estimation equation. Total bilirubin 
level was not included in our analysis as a candidate parameter, although it also correlated 
significantly with ICGR15. To account for this omission, total bilirubin levels remained 
as a significant variable in the multiple linear regression analysis. However, such an 
equation would not be applicable in patients with biliary obstruction because, in many 
hospitals in Japan, surgical indication in patients with biliary carcinoma is a total bilirubin 
level of 2 mg/ml [9]; however, the converted ICGR15 could be lower even at 2 mg/dl total 
bilirubin. Total bilirubin levels were therefore excluded in the present analysis to avoid 
such an influence of biliary obstruction.  
The remaining three parameters used for the multiple linear regression analysis were 
HA level and the two 99m-Tc GSA liver scintigraphy results, which were reliable 
parameters that have already been applied as referral parameters with ICGR15 [11, 18]. 
As a result, differences between actual and converted ICGR15, or differences of ICGR15 
between patients with non-obstructed and obstructed jaundice, did not show remarkable 
significance. In addition, the standard deviation was large in comparison with  the mean 
value. In some cases, other background factors might also have influenced the GSA or 
hyaluronic acid level, but we could not clarify these factors at this stage. It was necessary 
to revise the present formula for minimizing large standard deviation by applying other 
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associated parameters. As shown in the results, a decreased difference was more frequent 
in obstructive jaundice in comparison with non-obstructive jaundice, as we expected.  
The goal of the present study was to apply the converted ICGR15 in patients with 
obstructive jaundice to accurately evaluate operative indication for the extent of 
hepatectomy. In the present study, for example, patient outcomes in jaundiced liver were 
worse than in patients without jaundice. However, by applying the more adequate 
evaluation of ICGR15, it was possible to improve these patient outcomes. At this stage, 
however, it is difficult to determine definite cut-off levels of the converted ICGR15 for 
decisions on major hepatectomy. A future prospective study using the converted ICGR15 
presented here may clarify this problem. 
Several studies have shown that a lower level of 99mTc-GSA clearance was 
associated with posthepatectomy complications [19, 24-27]. For example, Kokudo et al. 
[27] reported that levels of the hepatic receptor for 99mTc-GSA in the remnant liver were 
closely associated with morbidity after hepatectomy. The HA level was also correlated 
with posthepatectomy complications by previous reports, including a previous study of 
our own [18, 23]. Therefore, the converted ICGR15 calculated by these parameters may 
also be useful for predicting posthepatectomy complications or mortality.  
The differences between the measured (actual) ICGR15 and the obtained converted 
ICGR15 were also examined. In some cases, a large difference between the actual and 
converted ICGR15 was observed, particularly in patients with biliary obstruction. A 
decrease in the converted ICGR15 was also frequently observed in such patients 
compared to those without biliary obstruction. Specifically, hepatic functional evaluation 
including the ICGR15 test was performed in 42 patients with biliary obstruction when the 
total bilirubin level was below 2 mg/ml. Therefore, the actual ICGR15 might still have 
been affected by bile congestion, and discrepancies with other hepatic functional 
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parameters might have occurred. In particular, previous reports including our preliminary 
study cited a discrepancy of 8% between ICGR15 and 99mTc-GSA liver scintigraphy, with 
these cases showing biliary obstruction or occult necroinflammatory or fibrotic findings 
[11]. Therefore, in patients with a large difference between the actual ICGR15 and 
99mTc-GSA liver scintigraphy, the latter result might be more useful in evaluating surgical 
indications for hepatectomy.  
The converted ICGR15 more closely reflects hepatic cellular function without the 
influence of a hepatic vascular shunt or a biliary obstruction. Regarding clinical 
application of the converted ICGR15, we have not yet decided to replace the conventional 
ICG test (=actual ICGR15) with the converted formula at our institute, as a conversion 
formula from a previous report [9] was different from our present formula. In addition, it 
is necessary to examine this conversion formula in a larger set of subjects through 
multi-center analysis before adoption. Another limitation is a higher cost for 99mTc-GSA 
liver scintigraphy in comparison with a ICGR15 test. Moving forward, we will measure 
both ICGR15 and 99mTc-GSA liver scintigraphy and apply the converted ICGR15 data to 
cases of biliary obstruction or cases with a large discrepancy between the actual ICGR15 
and the LHL15. 
In conclusion, we have provided a linear equation for calculating converted ICGR15 
based on serum HA levels and 99mTc-GSA liver scintigraphy findings (HH15 and LHL15), 
both of which are unlikely to be affected by biliary obstruction. The converted ICGR15 
tended to be lower in patients with biliary obstruction; however, this index could still be 
useful for evaluating hepatic function in patients with or without biliary obstruction who 
undergo major hepatectomy. This parameter is promising as a replacement of the 
conventional ICG test as the standard, reliable liver function test before hepatectomy. 
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Figure 1. a) Uptake of 99mTc-GSA in the heart and liver. b) Changes in uptake of 
99mTc-GSA in the heart and liver after injection. 
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TABLE 1  
Relationships among Various Hepatic Function Parameters and Indocyanine Green 
Retention Rate at 15 Minutes. 
 Mean±SD Correlation coefficient (r) P value 
HH15 0.603±0.100 0.583 <0.01 
LHL15 0.909±0.055 -0.620 <0.01 
AST (IU/L) 46±37 0.271 <0.01 
ALT (IU/L) 46±46 0.156 0.012 
Total cholesterol (mg/dl) 173±40 -0.248 <0.01 
Platelet count (/mm3) 18±10 -0.271 <0.01 
Prothrombin activity (%) 93±14 -0.391 <0.01 
Hyaluronic acid (ng/ml) 140±153 0.538 <0.01 
 
P values are based on Pearson's correlation analysis. 
HH15 and LHL15: Blood clearance index: uptake ratio of the heart at 15 min to that at 
3 min, and hepatic uptake ratio by 99mTc-GSA; AST: aspartate aminotransferase; ALT: 
alanine aminotransferase.
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TABLE 2  
Multiple Linear Regression Stepwise Method Output using Data of 265 Patients 
without Biliary Obstruction. 
Model Unstandardized coefficients Standardized coefficient 
t value 
Significance 
(p value)   Standard error 
Model 1 (Constant)    37.78 25.17  1.50 0.135 
Total cholesterol 0.006 0.015 0.021 0.398 0.691 
HH 15*100 0.31 0.11 0.255 20.79 0.006 
LHL15*100 -0.50 0.22 -0.221 -20.28 0.023 
AST 0.028 0.037 0.085 0.76 0.45 
ALT -0.029 0.026 -0.116 -0.10.12 0.27 
Platelet count 0.073 00.052 0.076 10.42 0.16 
Prothrombin activity -0.008 0.045 -0.010 -0.178 0.86 
Hyaluronic acid 0.021 0.005 0.271 40.12 <0.001 
Model 2 (Constant)    410.41 240.67  10.679 0.094 
HH 15*100 0.276 0.104 0.230 20.648 0.009 
LHL15*100 -0.501 0.213 -0.222 -20.35 0.020 
Hyaluronic acid 0.020 0.005 0.263 40.135 <0.001 
    
Dependent variable: Step 6 total. 
The standardized  coefficient provides a measure of the contribution of each variable to 
the model. The t and p values provide an indication of the impact of each predictor 
variable. 
Abbreviations as in Table 1. 
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TABLE 3  
Relationships between the Converted Indocyanine Green Retention Rate at 15 
Minutes and the Presence of Obstructive Jaundice in the Liver. 








     Benign liver disease 
     Hepatocellular carcinoma 
     Intrahepatic cholangiocarcinoma 
     Liver metastasis 
     Gallbladder carcinoma 
     Bile duct carcinoma 
Child-Pugh classification (A/B) 
Actual ICGR15 
Converted ICGR15 
  Difference of actual and converted ICGR15 
  Decrease of converted ICGR15 compared to    
           actual ICGR15 (No/yes) 
Total bilirubin level at operation (mg/dl) 
HH15 
LHL15 
Hyaluronic acid level (ng/ml) 
Blood loss (ml) 
Hemihepatectomy or more extended hepatectomy 
    No/Yes 
Postoperative outcomes 
   Prolonged ascites* 












































































* Ascites over 500 ml prolonged at 1 week after hepatectomy with use of diuretics. 
# Total bilirubin level over 5 mg/dl at 2 weeks after hepatectomy.   
